|
- Multi-disciplinary Center
with a faculty of basic scientists, pharmacologists, clinical investigators,
psychologists, nutritionists, and biostatistician from Departments of
Medicine, Pediatrics, Surgery, Obstetrics/Gynecology, Psychiatry, and
Pharmacology
- Grant support from national
and international governmental agencies, non-governmental foundations and
industry
- Basic research on germ cell
regulation, genetics of male infertility, pharmacologic interference of
spermatogenesis, nitric oxide and penile disorders, mechanisms of
reproductive aging, and animal models of genetic diseases
- Cutting edge technology:
microarray analysis, yeast hybrid systems, confocal microscopy, molecular
genetics, stable isotope measurement by high resolution mass spectroscopy,
high resolution brain, prostate, and bone imaging, etc
- Clinical research on
androgen metabolism, androgen replacement in hypogonadal men, and androgen
deficient older men, male contraceptive development studies, effects of
environmental, pharmaceutical and chemical toxicants on sperm production and
function in men, brain structure and function studies in patients with sex
chromosome disorders, and androgen effects on Alzheimer’s Disease and
multiple sclerosis.
a) The UCLA World
Health Organization (WHO) Collaborating Center in Human Reproduction is
located in the Martin Research Building and provides support for
Contraceptive Development. Collaborating Centers participate in multi-center
trials and basic approaches to male contraception. Dr. Wang serves as the
Chair of the Male Task Force of the World Health Organization effort on male
contraception.
Ronald S. Swerdloff, M.D., P.I.
b) The Harbor-UCLA
Mellon Foundation Reproductive Biology Center provides support for young
investigators, trainees, twinning grants with investigators in developing
countries, and pilot studies intended to enhance the development of new
approaches to male contraception and reproductive health.
Ronald S. Swerdloff, M.D., P.I
c) NIH, NICHD
Contraceptive Clinical Trials Center at Harbor-UCLA is one of two NIH
supported Centers of Excellence to identify and test new candidates for male
contraception.
Ronald S. Swerdloff, M.D., P.I.
|
|
